Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 57 , ISSUE 3 ( July-September, 2023 ) > List of Articles


Circulating Tumor Cells (CTCs) as a “Liquid Biopsy” Component: Where do We Stand?

Anshika Chauhan, Geeta S Boora, Arnab Pal

Citation Information : Chauhan A, Boora GS, Pal A. Circulating Tumor Cells (CTCs) as a “Liquid Biopsy” Component: Where do We Stand?. J Postgrad Med Edu Res 2023; 57 (3):105-107.

DOI: 10.5005/jp-journals-10028-1631

License: CC BY-NC 4.0

Published Online: 26-07-2023

Copyright Statement:  Copyright © 2023; The Author(s).


  1. Alix-Panabières C, Pantel K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov 2016;6(5):479–491. DOI: 10.1158/2159-8290.CD-15-1483
  2. Kujur PK, Flores BCT, Ramalingam N, et al. Advances in the characterization of circulating tumor cells in metastatic breast cancer: single cell analyses and interactions, and patient-derived models for drug testing. Adv Exp Med Biol 2020;1220:61–80. DOI: 10.1007/978-3-030-35805-1_5
  3. Wang Y, Kim TH, Fouladdel S, et al. PD-L1 expression in circulating tumor cells increases during radio(chemo)therapy and indicates poor prognosis in non-small cell lung cancer. Sci Rep 2019;9(1):566. DOI: 10.1038/s41598-018-36096-7
  4. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351(8):781–791. DOI: 10.1056/NEJMoa040766
  5. Negin BP, Cohen SJ. Circulating tumor cells in colorectal cancer: past, present, and future challenges. Curr Treat Options Oncol 2010;11 (1-2):1–13. DOI: 10.1007/s11864-010-0115-3
  6. Resel Folkersma L, Olivier Gomez C, San Jose Manso L, et al. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation. Archivos espanoles de urologia 2010;63(1):23–31.
  7. Fridrichova I, Kalinkova L, Ciernikova S. Clinical relevancy of circulating tumor cells in breast cancer: epithelial or mesenchymal characteristics, single cells or clusters? Int J Mol Sci 2022;23(20): DOI: 10.3390/ijms232012141
  8. Cieślikowski WA, Antczak A, Nowicki M, et al. Clinical relevance of circulating tumor cells in prostate cancer management. Biomedicines 2021;9(9): 1179. DOI: 10.3390/biomedicines9091179
  9. Mohamed Suhaimi NA, Foong YM, Lee DY, et al. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients. Mol Oncol 2015;9(4):850–860. DOI: 10.1016/j.molonc.2014.12.011
  10. Chauhan A, Kaur R, Ghoshal S, et al. Exploration of circulating tumour cell (CTC) biology: a paradigm shift in liquid biopsy. Indian J Clin Biochem 2021;36(2):131–142. DOI: 10.1007/s12291-020-00923-4
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.